- Home
- NUWE vs PRFX Comparison
NUWE vs PRFX Comparison
Compare NUWE & PRFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NUWE
- PRFX
- Stock Information
- Founded
- NUWE 1999
- PRFX 2007
- Country
- NUWE United States
- PRFX Israel
- Employees
- NUWE N/A
- PRFX N/A
- Industry
- NUWE Biotechnology: Electromedical & Electrotherapeutic Apparatus
- PRFX Biotechnology: Pharmaceutical Preparations
- Sector
- NUWE Health Care
- PRFX Health Care
- Exchange
- NUWE Nasdaq
- PRFX Nasdaq
- Market Cap
- NUWE 2.9M
- PRFX 2.5M
- IPO Year
- NUWE N/A
- PRFX 2020
- Fundamental
- Price
- NUWE $2.86
- PRFX $1.24
- Analyst Decision
- NUWE
- PRFX Hold
- Analyst Count
- NUWE 0
- PRFX 1
- Target Price
- NUWE N/A
- PRFX N/A
- AVG Volume (30 Days)
- NUWE 138.1K
- PRFX 145.5K
- Earning Date
- NUWE 11-12-2025
- PRFX 11-14-2025
- Dividend Yield
- NUWE N/A
- PRFX N/A
- EPS Growth
- NUWE N/A
- PRFX N/A
- EPS
- NUWE N/A
- PRFX N/A
- Revenue
- NUWE $8,318,000.00
- PRFX N/A
- Revenue This Year
- NUWE $6.53
- PRFX N/A
- Revenue Next Year
- NUWE $51.63
- PRFX N/A
- P/E Ratio
- NUWE N/A
- PRFX N/A
- Revenue Growth
- NUWE N/A
- PRFX N/A
- 52 Week Low
- NUWE $2.72
- PRFX $1.20
- 52 Week High
- NUWE $175.98
- PRFX $16.63
- Technical
- Relative Strength Index (RSI)
- NUWE 38.54
- PRFX 43.84
- Support Level
- NUWE $3.01
- PRFX $1.25
- Resistance Level
- NUWE $4.00
- PRFX $1.34
- Average True Range (ATR)
- NUWE 0.26
- PRFX 0.07
- MACD
- NUWE 0.03
- PRFX 0.00
- Stochastic Oscillator
- NUWE 10.94
- PRFX 23.53
About NUWE Nuwellis Inc.
Nuwellis Inc is a medical technology company focused on developing, manufacturing, and commercializing a medical device used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.
About PRFX PainReform Ltd.
PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.